International audienceNon-transplanted and transplanted patients with chronic kidney disease (CKD) differ in terms of mortality and the risk of clinical events. This difference is probably due to the difference of both traditional and non-traditional risk factors. Uremic retention solutes may constitute important non-traditional risk factors in this population. In the present review, we selected a set of uremic toxins that have been associated with harmful effects, and are an appealing target for adjuvant therapy in CKD. For each toxin reviewed here, relevant studies were selected and the relationship with hard clinical outcomes of uremic toxins were compared between non-transplanted CKD patients and transplanted patients taking into accoun...
Acute kidney injury (AKI) is a serious and frequent condition which may fully resolve but is associa...
in the progression of cardiovascular disease in patients with CKD. Further studies are needed to bet...
Chronic kidney disease is characterized by a progressive reduction of glomerular filtration rate and...
International audienceNon-transplanted and transplanted patients with chronic kidney disease (CKD) d...
Patients with chronic kidney disease (CKD) are at a high risk for cardiovascular disease (CVD), and ...
In the review, the author returns to the topic of uremia and uremic toxins, their importance for pra...
BackgroundRetention of uremic toxins in patients with chronic kidney disease (CKD) negatively affect...
International audiencePatients with chronic kidney disease (CKD) have an elevated prevalence of athe...
Uremic toxin (UT) retention in chronic kidney disease (CKD) affects biological systems. We aimed to ...
In patients with chronic kidney disease (CKD), adequate renal clearance is compromised, resulting in...
International audienceBackground: Indoxyl sulfate (IS) is a protein-bound uremic toxin that is known...
Background: Indoxyl sulfate (IS) is a protein-bound uremic toxin that is known to be associated with...
Acute kidney injury (AKI) is a serious and frequent condition which may fully resolve but is associa...
in the progression of cardiovascular disease in patients with CKD. Further studies are needed to bet...
Chronic kidney disease is characterized by a progressive reduction of glomerular filtration rate and...
International audienceNon-transplanted and transplanted patients with chronic kidney disease (CKD) d...
Patients with chronic kidney disease (CKD) are at a high risk for cardiovascular disease (CVD), and ...
In the review, the author returns to the topic of uremia and uremic toxins, their importance for pra...
BackgroundRetention of uremic toxins in patients with chronic kidney disease (CKD) negatively affect...
International audiencePatients with chronic kidney disease (CKD) have an elevated prevalence of athe...
Uremic toxin (UT) retention in chronic kidney disease (CKD) affects biological systems. We aimed to ...
In patients with chronic kidney disease (CKD), adequate renal clearance is compromised, resulting in...
International audienceBackground: Indoxyl sulfate (IS) is a protein-bound uremic toxin that is known...
Background: Indoxyl sulfate (IS) is a protein-bound uremic toxin that is known to be associated with...
Acute kidney injury (AKI) is a serious and frequent condition which may fully resolve but is associa...
in the progression of cardiovascular disease in patients with CKD. Further studies are needed to bet...
Chronic kidney disease is characterized by a progressive reduction of glomerular filtration rate and...